NASDAQ: EGRX - Eagle Pharmaceuticals, Inc.

Доходность за полгода: -69.27%
Дивидендная доходность: 0.00%
Сектор: Healthcare

График акции Eagle Pharmaceuticals, Inc.

Расширенный график Простой график
Financial Markets by TradingView

О компании Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma.

подробнее
Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Добавить в список сравнения
Добавить в список отслеживания
Добавить в портфель
Добавить уведомление о цене

IPO date 2014-02-12
ISIN US2697961082
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.eagleus.com
Цена ао 1.3
Изменение цены за день: 0% (1.3)
Изменение цены за неделю: +52.94% (0.85)
Изменение цены за месяц: +10.17% (1.18)
Изменение цены за 3 месяца: +73.33% (0.75)
Изменение цены за полгода: -69.27% (4.23)
Изменение цены за год: -78.15% (5.95)
Изменение цены за 3 года: -97.49% (51.83)
Изменение цены за 5 лет: -97.53% (52.71)
Изменение цены за 10 лет: 0% (1.3)
Изменение цены с начала года: +150% (0.52)
Все параметры

Недооценка

Название Значение Оценка
P/S 1.2 9
P/BV 1.63 8
P/E 10.67 9
EV/EBITDA 5.92 9
Итого: 9

Эффективность

Название Значение Оценка
ROA, % 10.8 4
ROE, % 17.39 5
Итого: 4.5

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0.2257

Долг

Название Значение Оценка
Debt/EBITDA 0.9542 9
Итого: 7.2

Импульс роста

Название Значение Оценка
Доходность Revenue, % 48.43 6
Доходность Ebitda, % 91.84 9
Доходность EPS, % 30.52 5
Итого: 4.4
Подробнее

Институционалы Объем Доля, %
Blackrock Inc. 984908 7.58
Janus Henderson Group PLC 775525 5.97
Brandes Investment Partners L.P. 745080 5.74
Vanguard Group Inc 638124 4.91
Millennium Management LLC 522402 4.02
AQR Capital Management, LLC 493665 3.8
LSV Asset Management 391758 3.02
Morgan Stanley 296864 2.29
Renaissance Technologies, LLC 294450 2.27
Acadian Asset Management. LLC 287555 2.21

ETFДоля, %Доходность за год, %Дивиденды, %
Royce Quant Small‑Cap Quality Value ETF 0.19827 21.83 1.62596
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01366 17.58 1.75869
iShares Micro-Cap ETF 0.01037 17.09 1.54048
Schwab U.S. Small-Cap ETF 0.00121 17.47 1.51433
0.0618.491.61



Руководитель Должность Оплата Год рождения
Mr. Michael Graves Interim Principal Executive Officer & Executive Chairman of the Board 160k 1963 (62 года)
Dr. Valentin R. Curt M.D. Senior Vice President of Clinical Drug Development N/A
Dr. Gaozhong Zhu Ph.D. Senior Vice President of Pharmaceutical Development N/A
Mr. Reed McClung Executive Vice President of Oncology Business Development N/A
Mr. Steven B. Ratoff Interim CFO, Principal Accounting Officer & Director 100k 1943 (82 года)
Mr. Daniel O'Connor Executive VP, Chief Strategy Officer & Head of Corporate Development 1980 (45 лет)
Ms. Debra Marie Hussain Senior VP & Head of Commercial 1968 (57 лет)

Адрес: United States, Woodcliff Lake. NJ, 50 Tice Boulevard - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.eagleus.com